PCM
BITI

Portolan Capital Management’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Portolan Capital Management’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-124,314
Closed -$1.78M – 159
2015
Q4 		$1.78M Buy
+124,314
New +$1.74M 0.23% 108

Other funds holding BITI

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return

Portolan Capital Management's BITI Position: Q1 2016 in Review

Portolan Capital Management sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q1 2016, closing a stake of 124,314 shares — an estimated $1.78M sold.

Portolan Capital Management first reported a position in BITI in Q4 2015 and held it in 1 quarter. The position peaked at $1.78M in Q4 2015. 19 funds tracked by Wall St. Rank hold BITI as of Q1 2016.

  • Portolan Capital Management reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q1 2016 after selling out during the quarter.
  • Portolan Capital Management sold 124,314 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q1 2016, an estimated $1.78M.
  • Portolan Capital Management first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q4 2015 and held it in 1 quarter.
  • Portolan Capital Management's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $1.78M in Q4 2015.
  • 19 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q1 2016.

Based on Portolan Capital Management's 13F filing for Q1 2016, filed 13 May 2016.